- Home
- FORA vs ERNA Comparison
FORA vs ERNA Comparison
Compare FORA & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- ERNA
- Stock Information
- Founded
- FORA 2014
- ERNA 2018
- Country
- FORA United States
- ERNA United States
- Employees
- FORA N/A
- ERNA N/A
- Industry
- FORA Computer Software: Prepackaged Software
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- FORA Technology
- ERNA Health Care
- Exchange
- FORA Nasdaq
- ERNA Nasdaq
- Market Cap
- FORA 65.4M
- ERNA 56.4M
- IPO Year
- FORA N/A
- ERNA N/A
- Fundamental
- Price
- FORA $2.03
- ERNA $0.42
- Analyst Decision
- FORA Strong Buy
- ERNA
- Analyst Count
- FORA 1
- ERNA 0
- Target Price
- FORA $5.00
- ERNA N/A
- AVG Volume (30 Days)
- FORA 16.9K
- ERNA 30.7M
- Earning Date
- FORA 11-13-2024
- ERNA 03-13-2025
- Dividend Yield
- FORA N/A
- ERNA N/A
- EPS Growth
- FORA N/A
- ERNA N/A
- EPS
- FORA N/A
- ERNA N/A
- Revenue
- FORA $19,709,723.00
- ERNA $598,000.00
- Revenue This Year
- FORA N/A
- ERNA N/A
- Revenue Next Year
- FORA $13.59
- ERNA N/A
- P/E Ratio
- FORA N/A
- ERNA N/A
- Revenue Growth
- FORA N/A
- ERNA 1072.55
- 52 Week Low
- FORA $1.96
- ERNA $0.22
- 52 Week High
- FORA $4.15
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- FORA 45.43
- ERNA 54.72
- Support Level
- FORA $1.96
- ERNA $0.38
- Resistance Level
- FORA $2.11
- ERNA $0.96
- Average True Range (ATR)
- FORA 0.08
- ERNA 0.10
- MACD
- FORA 0.00
- ERNA 0.03
- Stochastic Oscillator
- FORA 42.13
- ERNA 24.25
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.